Cargando…

Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review

Extracorporeal membrane oxygenation (ECMO) increases circulating blood volume, causes capillary leak and temporarily alters kidney function. Consequently, pharmacokinetics (PK) can be affected. When applied to neonates and infants, additional dose adjustments are a major concern, as the volume of di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yalcin, Nadir, Sürmelioğlu, Nursel, Allegaert, Karel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639121/ https://www.ncbi.nlm.nih.gov/pubmed/36437518 http://dx.doi.org/10.1136/bmjpo-2022-001512

Ejemplares similares

Pharmacotherapy during neonatal extracorporeal membrane oxygenation: toward an evidence-based approach
por: Rayyan, Maissa, et al.
Publicado: (2007)

The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review
por: Yalçin, Nadir, et al.
Publicado: (2022)

Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
por: Yang, Seungwon, et al.
Publicado: (2017)

Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation
por: Lee, Dong-Hwan, et al.
Publicado: (2021)

A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation
por: Mousavi, S., et al.
Publicado: (2011)

Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy
por: Hahn, Jongsung, et al.
Publicado: (2019)

Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review
por: Sutiman, Natalia, et al.
Publicado: (2020)

Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation
por: Kim, Yong Kyun, et al.
Publicado: (2022)

1109. Pharmacokinetics and Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)
por: Kois, Abigail K, et al.
Publicado: (2021)

Transportation of Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Broman, L. Mikael, et al.
Publicado: (2016)

Prior Antiplatelet Therapy and Stroke Risk in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation
por: Oh, Tak-Kyu, et al.
Publicado: (2021)

Clinical effect of early enteral nutrition support on critically ill neonates with extracorporeal membrane oxygenation
por: Lin, Ze-Wei, et al.
Publicado: (2023)

Pharmacokinetics and Monte Carlo Simulation of Meropenem in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2021)

Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Lyster, Haifa, et al.
Publicado: (2023)

Patient selection for neonatal extracorporeal membrane oxygenation: beyond severity of illness
por: Chapman, R L, et al.
Publicado: (2009)

Use of Extracorporeal Membrane Oxygenation in Pneumocystis Pneumonia of an Infant with AIDS
por: Cane, Grégoire, et al.
Publicado: (2020)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis
por: Gijsen, Matthias, et al.
Publicado: (2021)

Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)
por: Cheng, Vesa, et al.
Publicado: (2022)

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study
por: Ronda, Mar, et al.
Publicado: (2023)

The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics
por: Peitz, Gregory J., et al.
Publicado: (2023)

Postcardiotomy Extracorporeal Membrane Oxygenation in Neonates
por: Yu, Xindi, et al.
Publicado: (2021)

Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study
por: Alihodzic, Dzenefa, et al.
Publicado: (2022)

Clinical pharmacokinetics of vancomycin in the neonate: a review
por: Pacifici, Gian Maria, et al.
Publicado: (2012)

Dose Optimization of Meropenem in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Cardiac Patients: Pharmacokinetic/Pharmacodynamic Modeling
por: Kang, Soyoung, et al.
Publicado: (2022)

972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO)
por: Fratoni, Andrew J, et al.
Publicado: (2023)

Sequestration of Voriconazole and Vancomycin Into Contemporary Extracorporeal Membrane Oxygenation Circuits: An in vitro Study
por: Raffaeli, Genny, et al.
Publicado: (2020)

Nursing of Patients Critically Ill With Coronavirus Disease Treated With Extracorporeal Membrane Oxygenation
por: Tu, Zhongyu, et al.
Publicado: (2020)

Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19
por: Jozwiak, Mathieu, et al.
Publicado: (2020)

Five critically ill pregnant women/parturients treated with extracorporeal membrane oxygenation
por: Li, Ying, et al.
Publicado: (2022)

Pharmacokinetics of anidulafungin during venovenous extracorporeal membrane oxygenation
por: Aguilar, Gerardo, et al.
Publicado: (2016)

Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial – a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial
por: Suk, Pavel, et al.
Publicado: (2023)

Minimized Hemodiafiltration for Extracorporeal Membrane Oxygenation in Infants
por: Kwapil, Nicola, et al.
Publicado: (2023)

Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy
por: Hahn, Jongsung, et al.
Publicado: (2021)

Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation
por: Touchard, Cyril, et al.
Publicado: (2018)

Role of extracorporeal membrane oxygenation in critically Ill COVID‐19 patients and predictors of mortality
por: Zayat, Rashad, et al.
Publicado: (2020)

Anti-Factor-Xa and Activated Partial Thromboplastin Time Concordance and Outcomes in Adults Undergoing Extracorporeal Membrane Oxygenation: A Secondary Analysis of the Pilot Low-Dose Heparin in Critically Ill Patients Undergoing Extracorporeal Membrane Oxygenation Randomized Trial
por: Aubron, Cécile, et al.
Publicado: (2023)

Electroencephalographic features in patients undergoing extracorporeal membrane oxygenation
por: Peluso, Lorenzo, et al.
Publicado: (2020)

Bloodstream infections in patients undergoing extracorporeal membrane oxygenation
por: Wang, Jian-rong, et al.
Publicado: (2020)

Oxidative Stress and Neonatal Respiratory Extracorporeal Membrane Oxygenation
por: Raffaeli, Genny, et al.
Publicado: (2018)

Pharmacokinetics and Monte Carlo Dosing Simulations of Imipenem in Critically Ill Patients with Life-Threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation
por: Jaruratanasirikul, Sutep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_um3940srq26or44tir2iquj2sc